Business Wire

Universal Peace Federation Launches “THINK TANK 2022” to Reunify Korean Peninsula During Virtual 6th Rally of Hope

11.5.2021 08:00:00 EEST | Business Wire | Press release

Share

World leaders and experts joined more than a million global participants for the launch of “Think Tank 2022” on May 9 KST during the virtual 6th Rally of Hope for the peaceful reunification of the Korean Peninsula.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210510006060/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

José Manuel Barroso, former European Commission President addressing the global audience during the virtual 6th Rally of Hope and the launching of “THINK TANK 2022” (Photo: Business Wire)

The rally, sponsored by the Universal Peace Federation (UPF), was streamed live from South Korea to 194 nations and translated into 14 languages. Think Tank 2022 is a global multi-sector network of more than 2,000 experts from a wide range of fields—government, business, academia, faith, media, arts and culture—dedicated to the collaborative search for solutions to the world’s most critical challenges.

World-class leaders including the rally’s 12 keynote speakers affirmed and enhanced the concept of Think Tank 2022. “This network will make a difference for peace on the Korean Peninsula through international unity,” said Ban Ki-Moon, former United Nations Secretary-General and chairman of the new initiative. “I applaud Dr. Hak Ja Han Moon, UPF, and the leaders of Think Tank 2022.”

Former European Commission President José Manuel Barroso reminded the audience, that “peace also includes goodwill, trust and justice. The foundation of peace is each human being. The coronavirus taught us the lesson that we have to act and cooperate on a global scale.” “As leaders from around the world who cherish the values of faith, family, democracy and justice under law,” said former U.S. Vice President Mike Pence. “I commend you for coming together at this event to continue to sow the seeds of peace, believing that in time we will reap a harvest of peace that will benefit the people of Korea, the United States and all mankind.”

Born in present-day North Korea, UPF co-founders Dr. Hak Ja Han Moon and her late husband, Rev. Dr. Sun Myung Moon, fled to the south during the Korean War and have devoted their lives to advancing a more peaceful world and reuniting Korea. Think Tank 2022, will spearhead peacebuilding initiatives such as a UN Peace Park on the DMZ; building a Korea-Japan undersea tunnel; boosting Geumgang Mountain tourism development; and helping separated Korean families find their relatives.

“A reunified, denuclearized Korean Peninsula will bring massive peace and prosperity to the peninsula and to the region,” said Mike Pompeo, former U.S. Secretary of State and CIA Director. “Religious freedom is indeed the foundation of all freedoms...with prayer, faith, and commitment to the Lord, peace will follow.”

Many speakers, including former Republic of Korea Prime Minister Chung Sye-Kyun and Cambodian Prime Minister Hun Sen, praised the timeliness of Think Tank 2022 where “international cooperation and solidarity is needed now more than ever,” said Chung.

From Africa, Zanzibar President Dr. Hussein Ali Mwinyi recalled that Africans took part in the Korean War and long for peace and democracy in that region. The peaceful reunification of Korea will lead to “explosive growth,” said renowned American businessman and investor Mr. Jim Rogers. “If trains run through the DMZ and cars run on highways, there will be endless economic development opportunities...benefiting not only the two Koreas, but also China, Russia, Japan and Asia and the whole world.”

Mr. David Beasely, executive director of the United Nations World Food Programme, the world’s largest humanitarian organization and 2020 recipient of the Nobel Peace Prize, said, “This rally is reaching across continents, uniting people all over the world in a spirit of peace, mutual prosperity and public service.”

Governments have failed because they couldn’t go beyond “their bureaucracies, their biases, and their fears,” said Newt Gingrich, former U.S. Speaker of the House of Representatives. Think Tank 2022 offers a new way for people from multiple nations to work together “outside the traditional, formal structures” he said.

“Times of crisis often tend to be the moments of greatest opportunity,” said Mark Esper, former U.S. Secretary of Defense.

"Prof. Sarah Gilbert, co-developer of the Oxford/Astra-Zeneca vaccine said that great advances would result from the challenge of the pandemic, including much speedier development of vaccines to cope with new and mutant viruses. Much greater cooperation between nations was needed to ensure the effective roll-out of the currently available vaccines to nations afflicted by the pandemic as well as greater generosity on the part of richer nations to poorer ones".

The 6th Rally of Hope, part of a digital series started by Dr. Moon in August 2020, has brought together tens of millions of people worldwide who embrace freedom, peace, and unity based on the shared ideals of interdependence, mutual prosperity, and universal values. The Washington Times article on the rally is available here.

Rally of Hope Website (video with highlights of the event): https://www.rallyofhope.eu

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media:
Peter Zoehrer, UPF Media Relations - Europe & Middle East
+43 (0)6645238794
media@europe.upf.org
UPF.ORG & EUME.UPF.ORG

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 17:18:00 EEST | Press release

Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 15:30:00 EEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 14:45:00 EEST | Press release

Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye